Research Article published by Elsevier Volume 132, Issue 3, 18 December 2008An effective therapeutic regimen is available for the treatment of tuberculosis (TB), however in developing countries; patient non-compliance due to high dose frequency and the lengthy duration of treatment, presents a major challenge, thus resulting in treatment failure. To address this challenge, the project seeks to develop a nano-drug delivery system whereby anti-TB drugs can be administered in a single dose that maintains an active level of the drug for at least one week
Tuberculosis has claimed its victims throughout much of known human history and is currently the mos...
Tuberculosis (TB) is the second most deadly infectious disease. Despite potentially curative pharmac...
Despite the fact that we live in an era of advanced technology and innovation, infectious diseases, ...
Research Article published by Expert Opinion on Drug Delivery Volume 10, Issue 1220 -13Introduction...
Tuberculosis, commonly known as TB, is the second most fatal infectious disease after AIDS, caused b...
Tuberculosis (TB) is one of the ten infectious diseases that cause the highest amount of human morta...
The appearance and rapid spread of drug resistant strains of tuberculosis (TB), one of the deadliest...
357-366The era of nanotechnology has allowed new research strategies to flourish in the field of dr...
Tuberculosis (TB) is an old disease that may have coexisted with humans for at least 15,000 years b...
Tuberculosis (TB) had been a leading chronic bacterial infection since decades. Current therapeutic ...
Tuberculosis (TB) is a leading chronic bacterial infection. Despite potentially curative pharmacothe...
Tuberculosis (TB) is a global health crisis, with millions of cases and deaths annually. Drug-resist...
Despite the fact that we live in an era of advanced technology and innovation, infectious diseases, ...
Tuberculosis (TB) is currently the second deadliest infectious disease. Existing antitubercular ther...
Tuberculosis (TB) is the main infectious disease causing 1.8 million deaths worldwide every year and...
Tuberculosis has claimed its victims throughout much of known human history and is currently the mos...
Tuberculosis (TB) is the second most deadly infectious disease. Despite potentially curative pharmac...
Despite the fact that we live in an era of advanced technology and innovation, infectious diseases, ...
Research Article published by Expert Opinion on Drug Delivery Volume 10, Issue 1220 -13Introduction...
Tuberculosis, commonly known as TB, is the second most fatal infectious disease after AIDS, caused b...
Tuberculosis (TB) is one of the ten infectious diseases that cause the highest amount of human morta...
The appearance and rapid spread of drug resistant strains of tuberculosis (TB), one of the deadliest...
357-366The era of nanotechnology has allowed new research strategies to flourish in the field of dr...
Tuberculosis (TB) is an old disease that may have coexisted with humans for at least 15,000 years b...
Tuberculosis (TB) had been a leading chronic bacterial infection since decades. Current therapeutic ...
Tuberculosis (TB) is a leading chronic bacterial infection. Despite potentially curative pharmacothe...
Tuberculosis (TB) is a global health crisis, with millions of cases and deaths annually. Drug-resist...
Despite the fact that we live in an era of advanced technology and innovation, infectious diseases, ...
Tuberculosis (TB) is currently the second deadliest infectious disease. Existing antitubercular ther...
Tuberculosis (TB) is the main infectious disease causing 1.8 million deaths worldwide every year and...
Tuberculosis has claimed its victims throughout much of known human history and is currently the mos...
Tuberculosis (TB) is the second most deadly infectious disease. Despite potentially curative pharmac...
Despite the fact that we live in an era of advanced technology and innovation, infectious diseases, ...